Hongmei Xu

Company: Bicycle Therapeutics

Job title: Head Vice President, Quantitative Pharmacology

Seminars:

Dose Evaluation for Bicycle Bispecific using Quantitative System Pharmacology (QSP) Modeling 9:30 am

Considerations and challenges of dose optimization in bispecifics Translational thinking incorporating preclinical and clinical data Role of QSP modelling in bispecific dose optimizationRead more

day: Conference Day One

Roundtable Discussion: Subcutaneous vs. UV Dosing: Different Approaches Required for Changing Dosing from a Clinician’s Perspective 1:30 pm

Comparing the patient experience and practical considerations of switching from IV to subcutaneous dosing Understanding how route of administration impacts PK, tolerability, and trial design decisions Exploring what it takes to make the transition between dosing routes work for patients and studiesRead more

day: Conference Day One